Research Grant
[Cite as https://purl.org/au-research/grants/nhmrc/510130]Researchers: Prof Steven Krilis (Principal investigator)
Brief description The major protein that the antibodies in the antiphospholipid syndrome (APS) bind is called Beta 2-GPI. Antibodies to Beta 2-GPI are associated with recurrent miscarriage, intrauterine growth retardation, clots and stroke. Treatment of patients with the APS are treated with medication that has significant side effects. The development of more targeted and effective therapies for the APS requires a greater understanding of how the antibodies cause their effects, which is addressed in this study.
Funding Amount $AUD 530,591.62
Funding Scheme NHMRC Project Grants
Notes Standard Project Grant
- nhmrc : 510130
- PURL : https://purl.org/au-research/grants/nhmrc/510130
